Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 2
1961 2
1964 1
1965 1
1973 2
1978 1
1980 1
1981 1
1982 1
1985 1
1986 2
1988 1
1989 1
1990 1
1991 9
1992 13
1993 12
1994 30
1995 19
1996 24
1997 35
1998 34
1999 35
2000 33
2001 42
2002 43
2003 42
2004 45
2005 46
2006 57
2007 60
2008 73
2009 69
2010 84
2011 74
2012 69
2013 65
2014 65
2015 65
2016 55
2017 54
2018 52
2019 46
2020 64
2021 85
2022 63
2023 56
2024 40
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,543 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.
Bjørklund G, Pivin M, Hangan T, Yurkovskaya O, Pivina L. Bjørklund G, et al. Autoimmun Rev. 2022 Aug;21(8):103135. doi: 10.1016/j.autrev.2022.103135. Epub 2022 Jun 9. Autoimmun Rev. 2022. PMID: 35690244 Review.
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive hereditary pathology that develops with endocrine and non-endocrine manifestations in childhood. ...APS-1 occurs because of mutations in the autoimmune regulator (AIRE) gene, leading to a dis
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive hereditary pathology that develops with endocrine and non-
Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.
Betterle C, Furmaniak J, Sabbadin C, Scaroni C, Presotto F. Betterle C, et al. J Endocrinol Invest. 2023 Apr;46(4):643-665. doi: 10.1007/s40618-022-01994-1. Epub 2023 Jan 7. J Endocrinol Invest. 2023. PMID: 36609775 Review.
BACKGROUND: The number of recognised distinct autoimmune diseases (AIDs) has progressively increased over the years with more than 100 being reported today. ...These combinations are collectively termed type 3 Autoimmune Polyglandular Syndrome (APS-3), also called t …
BACKGROUND: The number of recognised distinct autoimmune diseases (AIDs) has progressively increased over the years with more than 10 …
The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1).
Guo CJ, Leung PSC, Zhang W, Ma X, Gershwin ME. Guo CJ, et al. Autoimmun Rev. 2018 Jan;17(1):78-85. doi: 10.1016/j.autrev.2017.11.012. Epub 2017 Nov 4. Autoimmun Rev. 2018. PMID: 29108822 Review.
Autoimmune Polyglandular Syndrome type 1 (APS-1) is a subtype of the autoimmune polyendocrine syndrome characterized by the simultaneous or sequential dysfunction of multiple endocrine or non-endocrine glands. ...In this review, we provide a detailed critical overvi
Autoimmune Polyglandular Syndrome type 1 (APS-1) is a subtype of the autoimmune polyendocrine syndrome characterized by the si
Polyglandular autoimmune syndromes.
Kahaly GJ, Frommer L. Kahaly GJ, et al. J Endocrinol Invest. 2018 Jan;41(1):91-98. doi: 10.1007/s40618-017-0740-9. Epub 2017 Aug 17. J Endocrinol Invest. 2018. PMID: 28819917 Review.
METHODS: Review of the pertinent and current literature. RESULTS: Polyglandular autoimmune syndromes (PAS) are multifactorial diseases with at least two coexisting autoimmune-mediated endocrinopathies. PAS show a great heterogeneity of syndromes and manifest sequent …
METHODS: Review of the pertinent and current literature. RESULTS: Polyglandular autoimmune syndromes (PAS) are multifactorial disease …
Autoimmune polyglandular syndrome type 1 with diabetes insipidus: a case report.
Chen J, Lu T, Liu C, Zhao Y, Huang A, Hu X, Li M, Xiang R, Feng M, Lu H. Chen J, et al. BMC Endocr Disord. 2021 Aug 3;21(1):154. doi: 10.1186/s12902-021-00822-6. BMC Endocr Disord. 2021. PMID: 34344344 Free PMC article.
BACKGROUND: Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare monogenic inherited disease caused by mutations of the autoimmune regulator gene (AIRE). ...
BACKGROUND: Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare monogenic inherited disease caused by mutations of the auto
Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence.
Perniola R, Fierabracci A, Falorni A. Perniola R, et al. Front Immunol. 2021 Feb 26;12:606860. doi: 10.3389/fimmu.2021.606860. eCollection 2021. Front Immunol. 2021. PMID: 33717087 Free PMC article. Review.
The autoimmune polyglandular syndrome type 1 (APS1) is caused by pathogenic variants of the autoimmune regulator (AIRE) gene, located in the chromosomal region 21q22.3. ...The clinical diagnosis of APS1 is based on the classic triad idiopathic hypoparathyroidism (HP …
The autoimmune polyglandular syndrome type 1 (APS1) is caused by pathogenic variants of the autoimmune regulator (AIRE) gene, …
Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review.
Van den Driessche A, Eenkhoorn V, Van Gaal L, De Block C. Van den Driessche A, et al. Neth J Med. 2009 Dec;67(11):376-87. Neth J Med. 2009. PMID: 20009114 Free article. Review.
Type 1 diabetes mellitus (T1DM) results from autoimmune destruction of insulin-producing beta cells and is characterised by the presence of insulitis and &and beta-cell autoantibodies. Up to one third of patients develop an autoimmune polyglandular syndrome. Fif …
Type 1 diabetes mellitus (T1DM) results from autoimmune destruction of insulin-producing beta cells and is characterised by the prese …
Autoimmune polyglandular syndrome type 1 and the autoimmune regulator.
Ruan QG, She JX. Ruan QG, et al. Clin Lab Med. 2004 Mar;24(1):305-17. doi: 10.1016/j.cll.2004.01.008. Clin Lab Med. 2004. PMID: 15157567 Review.
The autoimmune polyglandular syndrome type I (APSI) is an auto-somal recessive disorder that is characterized by chronic mucocutaneous candidiasis, multiple autoimmune endocrinopathies, and ectodermal dystrophies. The gene that is responsible for APSI has been ident …
The autoimmune polyglandular syndrome type I (APSI) is an auto-somal recessive disorder that is characterized by chronic mucocutaneou …
The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.
Lankisch TO, Jaeckel E, Strassburg CP. Lankisch TO, et al. Semin Liver Dis. 2009 Aug;29(3):307-14. doi: 10.1055/s-0029-1233535. Epub 2009 Aug 12. Semin Liver Dis. 2009. PMID: 19676003 Review.
Autoimmune polyglandular syndromes are rare autoimmune endocrinopathies that are associated with nonendocrine autoimmunopathies. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), also named autoimmune polyglandular syndrome type
Autoimmune polyglandular syndromes are rare autoimmune endocrinopathies that are associated with nonendocrine autoimmunopathie
Autoimmune polyglandular syndrome type 1.
Obermayer-Straub P, Strassburg CP, Manns MP. Obermayer-Straub P, et al. Clin Rev Allergy Immunol. 2000 Apr;18(2):167-83. doi: 10.1385/CRIAI:18:2:167. Clin Rev Allergy Immunol. 2000. PMID: 10944704 Review. No abstract available.
1,543 results